Mishribai Mohanlal Medical Centre Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 12-07-2024
- Paid Up Capital ₹ 0.50 M
as on 12-07-2024
- Company Age 12 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.60 M
as on 12-07-2024
- Revenue 73.71%
(FY 2022)
- Profit 85.11%
(FY 2022)
- Ebitda -12.91%
(FY 2022)
- Net Worth 69.43%
(FY 2022)
- Total Assets -0.78%
(FY 2022)
About Mishribai Mohanlal Medical Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹2.60 M.
Yash Jain, Mamta Jain, Lalitkumar Jain, and Two other members serve as directors at the Company.
- CIN/LLPIN
U85191MH2011PTC225479
- Company No.
225479
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Dec 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Mishribai Mohanlal Medical Centre?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yash Jain  | Director | 18-Jun-2021 | Current |
| Mamta Jain | Director | 27-Dec-2011 | Current |
| Lalitkumar Jain | Director | 27-Dec-2011 | Current |
| Trupti Jain | Director | 27-Dec-2011 | Current |
| Narendrakumar Jain | Director | 27-Dec-2011 | Current |
Financial Performance of Mishribai Mohanlal Medical Centre.
Mishribai Mohanlal Medical Centre Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 73.71% increase. The company also saw a substantial improvement in profitability, with a 85.11% increase in profit. The company's net worth Soared by an impressive increase of 69.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mishribai Mohanlal Medical Centre?
In 2019, Mishribai Mohanlal Medical Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Siemens Financial Services Private Limited Creation Date: 13 Apr 2015 | ₹2.60 M | Open |
How Many Employees Work at Mishribai Mohanlal Medical Centre?
Unlock and access historical data on people associated with Mishribai Mohanlal Medical Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mishribai Mohanlal Medical Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mishribai Mohanlal Medical Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
